MAY 10th, 2023
EDUCATIONAL PEARL
Lemierre syndrome: rare complication of bacterial pharyngitis/tonsillitis, involving septic thrombophlebitis of the internal jugular vein.
Presenting Symptoms:
Often preceded by pharyngitis.
Other preceding conditions include mastoiditis, otitis, dental infections, pharyngeal abscesses, or infectious mononucleosis.
Clinical manifestations: fever, rigors, exudative tonsillitis, sore throat, dysphagia, trismus, unilateral neck pain, and tenderness, respiratory symptoms.
Signs of IJV thrombosis: neck tenderness, swelling, and/or induration over the neck, over the angle of the jaw, or along the SCM muscle.
Epidemiology:
Highest incidence occurred prior to the use of antibiotics.
After the introduction of penicillin, the incidence of LS has decreased dramatically.
It is now incredibly rare with a worldwide incidence rate of 1/1,000,000.
It typically affects young health adolescents and adults.
Etiology/Pathophysiology:
Begins with oropharyngeal infection.
Commonly caused by Fusobacterium necrophorum and Fusobacterium nucleatum.
F. necrophorum is part of the bacterial flora in the pharynx, GI, and female genital tract.
It is believed that conditions/environments that are conducive to F. necrophorum growth can lead to infection.
The infection can then spread from the oropharynx to the internal jugular vein.
At the IJV, septic thrombosis occurs because of intravascular coagulation, venous stasis, and intrinsic vessel osculation.
This leads to a systematic infection due to release of septic emboli.
Diagnosis:
Diagnosis is primarily clinical.
Further lab evaluation needed for patients presenting with concern for sepsis or with systemic inflammatory response syndrome (SIRS) criteria.
Blood cultures
70% of cases show Fusobacterium species.
Chest radiograph to evaluate septic emboli and other pulmonary complications.
Other imaging modalities used to evaluate functional or septic thrombosis of the IJV include:
Ultrasound
CT of the neck with contrast MRI
Treatment: Empiric antibiotic therapy: piperacillin-tazobactam, carbapenem, ceftriaxone.
Lemierre syndrome: IJV Imaging
Lemierre syndrome: early recognition and management. Canadian Medical Association Journal. Accessed 5 May 2023.
Further Readings:
Written by: Alexandria Bao